|
|
- Hill, WR, Pillsbury, MA, Argyria: The Pharmacology of Silver, The Williams & Wilkins Company, Baltimore, 1939.
- Fung, MC, DL Bowen, “Silver Products for Medical Indication: Risk-Benefit Assessment,” Clinical Toxicology, 1996; 34(1):119-26.
- Russell, AD, Path, FR, Hugo, WB, “Antimicrobial Activity and Action of Silver,” Prog Med Chem, 1994; 31:353.
- Pilcher JD, Sollmann T. Organic, Protein and Colloidal Silver Compounds; Their Antiseptic Efficiency and Silver-Ion Content as a Basis for Their Classification. J Lab Clin Med, 1922;301-10.
- CRC Handbook of Chemistry and Physics: 80th Edition, ed. by David R. Lide, CRC Press, Boca Raton, FL, 1999-2000; Section 4-27.
- Acel, D, “The Oligodynamic Action of Metals,” Biochem. Z., 1920; 112:23.
- Hall, RE, Bender, G, Marquis, RE, “Inhibitory and Cidal Antimicrobial Actions of Electrically Generated Silver Ions,” J Oral Maxillofac Surg, 1987; 45:783.
- Zhu, X, “Ag+ Concentration Determination of 10-25 ppm, uniform picoscalar, 95%+ oligodynamic silver hydrosol,” Miami, Department of Marine Biology, University of Miami, 2003.
- Argentyn 23 Lot # BR11, University of Miami, May 5th, 2004 – 100,000X magnification. (please list the version of the T.E.M. used at the university, the resolution, the staff or technician, their credentials and department at the Univ.).
- Goetz, A, Tracy, RL, Harris, FS, “The Oligodynamic Effect of Silver,” In: Silver In Industry, Chapter 16, edited by Lawrence Addicks, Reinhold Publishing Corp., NY, 1940; p. 403.
- Pilcher JD, Sollmann T. Organic, Protein and Colloidal Silver Compounds; Their Antiseptic Efficiency and Silver-Ion Content as a Basis for Their Classification. J Lab Clin Med, 1922;301-10.
- Goetz, A, Tracy, RL, Harris, FS, “The Oligodynamic Effect of Silver,” In: Silver In Industry, Chapter 16, edited by Lawrence Addicks, Reinhold Publishing Corp., NY, 1940; p. 401-29
- Grier, N, “Silver and Its Compounds,” p. 386-90; In: Disinfection, Sterilization and Preservation, S. Block, edit., Lea & Febiger, Philadelphia, PA, 1983.
|